Trump went on to say that the standards would cause unnecessary delays in the delivery of a possible vaccine. Several companies are currently in clinical trials for candidate vaccines.
” Why would [companies] must add great length to the process? We want people not to get sick. The vaccine is very important, ”Trump said, adding,“ I think it was a political decision more than anything else. ”
The Post reported on Tuesday that the guidance will require a median of two months of data on participants in vaccine clinical trials, to ensure that there is sufficient time to assess the safety of candidate vaccines. The new guidelines, intended to increase public confidence and transparency in the immunization process, would make it more difficult to authorize a vaccine to be distributed before election day.
When asked if his administration needed to improve confidence in the vaccine, Trump said he had “enormous confidence” in companies testing vaccines.
“I have enormous confidence in these massive companies that are so brilliantly organized based on what they’ve done with the tests,” Trump said.
“I see no reason why it should be delayed any further,” Trump said, adding that a delay of a few weeks in a vaccine could cost lives due to the coronavirus.
Trump predicted that a vaccine could be ready during the month of October and publicly lobbied the FDA for the approval process. Democrats have raised concerns about political pressure in the race for a vaccine.
Senior health officials appeared before a Senate panel earlier Wednesday and sought to reassure Americans skeptical about the politicization of a vaccine.
Trump has repeatedly broken with senior health officials over public health guidelines and his assessments of the threat posed by the virus.
Last week, Trump took issue with CDC Director Robert Redfield’s prediction that a possible vaccine would not be available to the general public until the end of the second quarter or third quarter of 2021. Trump insisted that Redfield had made a “mistake” and was “confused”. by questioning at a congressional hearing.
An FDA spokesperson declined to comment when asked about Trump’s remarks.